Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,793 | -33,310 | -27,220 | -19,933 | -12,048 |
| Depreciation Amortization | 99 | 450 | 351 | 252 | 737 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 53 |
| Accounts receivable | 11 | -102 | 14 | -98 | -47 |
| Other Working Capital | 1,501 | 217 | -528 | 596 | 1,786 |
| Other Operating Activity | -1,905 | 9,076 | 7,090 | 4,607 | 1,489 |
| Operating Cash Flow | $-10,088 | $-23,668 | $-20,292 | $-14,576 | $-8,028 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -1,100 | -1,068 | -1,068 | -1,045 |
| Other Investing Activity | -102 | -1,750 | -1,248 | -635 | 0 |
| Investing Cash Flow | $-171 | $-2,849 | $-2,316 | $-1,703 | $-1,045 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 401 | 804 | 369 | 369 | 369 |
| Debt Repayment | -757 | -9,349 | -9,349 | -6,349 | -6,349 |
| Common Stock Issued | 3,242 | 11,560 | 11,651 | 1,051 | 1,096 |
| Other Financing Activity | 4,666 | 17,888 | 18,226 | 18,589 | 19,065 |
| Financing Cash Flow | $7,552 | $20,904 | $20,896 | $13,660 | $14,181 |
| Beginning Cash Position | 14,705 | 20,318 | 20,318 | 20,318 | 20,318 |
| End Cash Position | 11,998 | 14,705 | 18,607 | 17,700 | 25,426 |
| Net Cash Flow | $-2,707 | $-5,613 | $-1,712 | $-2,619 | $5,108 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,088 | -23,668 | -20,292 | -14,576 | -8,028 |
| Capital Expenditure | -70 | -1,100 | -1,068 | -1,068 | N/A |
| Free Cash Flow | -10,158 | -24,767 | -21,360 | -15,644 | -8,028 |